Comment on: Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2

Abstract

Haoyong et al. [ [1] Haoyong Visceral fat area as a new predictor of short term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese subjects with a body mass index less than 35 kg/m2. Surg Obes Relat Dis. 2014; Google Scholar ] report factors that can predict surgical outcomes in a mildly obese Chinese diabetic population. Metabolic surgery is not a synonym for interventions in type 2 diabetes mellitus (T2DM) patients with a low body mass index (BMI), because the purpose of these procedures is to treat T2DM per se, rather than only to reduce weight [ [2] Shukla A.P. Ahn S.M. Patel R.T. Rosenbaum M.W. Rubino F. Surgical treatment of type 2 diabetes: the surgeon perspective. Endocrine. 2011; 40: 151-161 Crossref PubMed Scopus (18) Google Scholar ]. Thus, it seems adequate to employ metabolic surgery in patients with mild obesity or even overweight with uncontrolled T2DM after rigorous medical and lifestyle interventions [ [3] Cohen R. Caravatto P. Petry T. Metabolic surgery for type 2 diabetes in patients with a BMI of<35 kg/m2: a surgeon’s perspective. Obes Surg. 2013; 23: 809-818 Crossref PubMed Scopus (12) Google Scholar ]. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2Surgery for Obesity and Related DiseasesVol. 11Issue 1PreviewMetabolic surgery has been proposed for inadequately controlled type 2 diabetes mellitus (T2DM) in association with obesity. However, prediction of successful T2DM remission after surgery has not been clearly studied in Chinese patients. The objective of this study was to predict the outcome in those with T2DM after metabolic surgery to help in patient selection. Full-Text PDF